Case Reports in Oncology

Case report of Tumour heterogeneity are related in differences between tumours of the same type in different patients, and also difference between cancer cells within a tumour cells can show distinct  including cellular morphology, motility, gene expression, proliferation, metabolism, and metastatic potential. This process occurs both between tumours which is called as inter-tumour heterogeneity and within tumours called as intra-tumour heterogeneity. It plays a major role in brain Cancer.

Genetic and epigenetic differences between cancer cells within a tumour might explain why some tumour cells remain present in the patient even after cancer treatment has finished. Most current efforts are focused on understanding heterotypic interactions between tumor cells and surrounding normal cells, which is known about the interactions between and among heterogeneous tumor cells within a neoplasm. Tumor Heterogeneity covers Inter- intra tumour heterogeneity, Cancer Stem Cells, Brain Tumor Microenvironment, Experimental- Sequencing, Genetic Heterogeneity and Implications and challenges

Tumour heterogeneity describes the observation that different tumour cells can show distinct morphological and phenotypic profiles, including cellular morphology, gene expression, metabolism, motility, proliferation, and metastatic potential. This phenomenon occurs both between tumours (inter-tumour heterogeneity) and within tumours (intra-tumour heterogeneity). The heterogeneity of cancer cells introduces significant challenges in designing effective treatment strategies. However, research into understanding and characterizing heterogeneity can allow for a better understanding of the causes and progression of disease. In turn, this has the potential to guide the creation of more refined treatment strategies that incorporate knowledge of heterogeneity to yield higher efficacy

  • Cancer cell biology
  • Clinical trials in cencer biology
  • Clinical trial design in Neuroscience
  • Clinical Oncology
  • Role of immunotherapy in GSCs
  • Antitumor Activity

Related Conference of Case Reports in Oncology

November 20-21, 2017

28th International Conference on Psychiatry & Mental Health

Melbourne, Australia
February 22-23, 2018

10th International Conference on Vascular Dementia

Paris, France
June 18-20, 2018

25th World Congress on Neurology & Neuroscience

Dublin, Ireland

November 5-6, 2018

World Summit on Spine and Spinal Disorders

San Franciso, USA
June 08-09, 2018

World Summit on Stroke & Neurological Disorders

Baltimore, Maryland, USA
June 14-16, 2018

3rd International Conference and Exhibition on Dual Diagnosis

Amsterdam, Netherlands
July 16-17, 2018

25th World Congress on Neurology and Neurodisorders

Melbourne, Australia
August 06-08, 2018

26th European Neurology Congress

Madrid, Spain
August 29-30, 2018

4th World Congress on Parkinsons & Huntington Disease

Zurich, Switzerland
August 29-30, 2018

4th International Conference on Epilepsy & Treatment

Zurich, Switzerland
September 13-14, 2018

7th International Conference on Neurological Disorders & Stroke

Prague, Czech Republic
September 13-14, 2018

4th International Conference on Spine and Spinal Disorders

Prague, Czech Republic
September 19-20, 2018

4th World Congress on Epilepsy and Treatment

Singapore
September, 20-22

International Conference on Neurology & Health Care

Lisbon, Portugal

Case Reports in Oncology Conference Speakers

Recommended Sessions

Related Journals

Are you interested in